Dr. Gooderham is a Dermatologist and Medical Director at the SKiN Centre for Dermatology and an Investigator with Probity Medical Research. She is an Assistant Professor at Queens University and a Consultant Physician at the Peterborough Regional Health Centre. She is a fellow of the Royal College of Physicians and Surgeons of Canada.

Dr. Gooderham has been the principal investigator for 170 clinical trials, and she practices with a focus on inflammatory diseases of the skin. She also contributes to several peer-reviewed dermatology publications as an associate editor, reviewer, and has been an author of 150 articles. She enjoys lecturing to global audiences on new therapies for skin diseases.

Dr. Shaun Goodman completed his Doctor of Medicine (1987) at McMaster University (Hamilton. Ontario) and a Master of Science in Clinical Epidemiology in the Faculty of Medicine and Graduate Department of Community Health at the University of Toronto (1998). He completed his training in Internal Medicine and Cardiology at the University of Toronto. He pursued a three-year Heart and Stroke Foundation of Canada-funded research fellowship before joining the Division of Cardiology at St. Michael’s Hospital in 1995.

Currently, Dr. Goodman is a Staff Cardiologist and Associate Head in the Division of Cardiology, Department of Medicine, at St. Michael’s Hospital, Toronto, Canada. He is Professor in the Department of Medicine at the University of Toronto. He is an Adjunct Professor in the Department of Medicine at the University of Alberta, a Co-Director of the Canadian VIGOUR (Virtual Coordinating Centre for Global Collaborative Cardiovascular Research) Centre (CVC), and Consultant to the Canadian Heart Research Centre (CHRC).

Dr. Goodman’s research interests include facilitating collaborative clinical trial, observational, and knowledge translation research in cardiovascular disease in Canada with a focus on diagnosis, management, and prognosis of stable coronary artery disease and acute coronary syndromes; secondary prevention of cardiovascular disease, including those with diabetes mellitus; and optimal stroke prevention risk stratification and management in atrial fibrillation.

Dr. Anatoly Langer graduated from the University of Manitoba in 1982 and completed his Internal Medicine and Cardiology training at the University of Toronto in 1987. After two years as a Heart and Stroke Foundation Research Fellow, he became a director of the Coronary Care Unit at St. Michael’s Hospital in Toronto, Canada. He is a fellow of the American College of Cardiology and Canadian Royal College of Physicians and Surgeons.

In 1996 Dr. Langer founded the Canadian Heart Research Centre with the goal of improving the care of cardiovascular patients through clinical trials research, physician and patient education, and information-sharing.

Dr. Langer has extensive research experience in the conduct of clinical trials with more than 25 years of experience in protocol design, study coordination, and data management. He has more than 300 peer-reviewed publications, abstracts, and book chapters. His areas of interest and research include pathophysiology and management of acute and stable coronary syndromes, as well as treatment and prevention of cardiovascular disease.

More recently, Dr. Langer has been a keen participant in the development of electronic health records, web-based applications for management of vital data and telemedicine, as well as innovations in data acquisition, disease management algorithms, and clinical decision-making support systems.

Dr. Langer has served for two years as an independent consultant on the Canadian Drug Evaluation Committee (CDEC) at CADTH. Currently, Dr. Langer is a Professor of Medicine at the University of Toronto and the Chair of the Canadian Heart Research Centre in Toronto and the International Centre for Professional Development in Health and Medicine in Montreal.

Dr. North completed his medical training at the University of Ottawa in 1994. Following that, he completed Internal Medicine and Medical Oncology training at the University of Alberta in 1999 and 2000, respectively. His keen interest in medical education led him to pursue a Master of Health Professions Education from the University of Illinois at Chicago, which he obtained in 2004. Dr. North is currently the Director of Medical Oncology at the Cross Cancer Institute in Edmonton and a Professor in the Department of Oncology, Faculty of Medicine and Dentistry at the University of Alberta. Since 1999, Dr. North has maintained an active practice focused on treating patients with genitourinary (GU) cancers.

From a research perspective, Dr. North has been involved as a principal or co-investigator on more than 50 interventional clinical trials spanning all tumour sites within GU oncology. Presently, he has over 140 peer-reviewed publications and is currently leading or participating in 16 interventional trials at the local level at the Cross Cancer Institute in Edmonton, AB. He is a former member of the Canadian Urologic Oncology Group executive and the GU executive of the Canadian Cancer Trials Group.

Dr. North is also an active clinical teacher at the undergraduate, graduate, and continuing medical education levels. In 2006, he received the Rutherford Award for Excellence in Undergraduate Teaching, the highest teaching award for undergraduate teaching at the University of Alberta. In 2011, he was awarded the 3M National Teaching Fellowship in recognition of his educational leadership and exceptional contributions to teaching the next generation of physicians.

Dr. Margie Oakander was raised in Calgary and completed undergraduate studies and residency at University of Calgary. Dr. Oakander is a Clinical Associate Professor with the Department of Psychiatry at University of Calgary.

Dr. Oakander is a consulting psychiatrist at the Community Addictions and Mental Health – NE Sunridge, where she is privileged to work with a dedicated multidisciplinary team of mental healthcare providers in an outpatient psychiatric clinic. She is Clinical Medical Director of Primary Care Liaison for the Calgary Region, which involves collaborating with programs and colleagues to bring effective psychiatric services to physicians in the community. Dr. Oakander is part of the Southern Alberta Shared Mental Health Care program, collaborating with family physicians in the medical home around the mental health concerns of their patients, and providing leadership through her role as Clinical Medical Director of the program. She consults at the Eastside Community Mental Health Service in Calgary, where she is part of a team providing single-session, solution-focused consultation in a unique walk-in counselling setting in a high-needs area of the city.

Dr. Oakander has been principal investigator in clinical trials in a variety of areas in psychiatry and has recently been involved in research-initiated projects in her interest areas. She has presented locally and abroad on topics related to walk-in, single-session, solution-focused therapy and has participated in publications on the topic.

Dr. Oakander has a passion for teaching. She is part of the Kolabo Team, providing collaborative broad-based mental health education to medical students in Mwanza, Tanzania. One of the most fulfilling aspects of her career is teaching undergraduate medical students, family practice and psychiatry residents, and multidisciplinary colleagues.

Originally from Saskatchewan, Dr. Stakiw completed her Bachelor of Science, MD and internal medicine training at the University of Saskatchewan prior to moving to Ontario to complete hematology training at Queen’s University, followed by a one-year fellowship at Princess Margaret Hospital in Toronto, ON in Lymphoma and Stem Cell Transplant.

After working as a hematologist-oncologist at Peel Regional Cancer Centre in Mississauga, Ontario for three years, she moved back to Saskatchewan. Dr. Stakiw has held several leadership positions, including Provincial Leader of Hematology for Saskatchewan, the Medical Director of the Saskatchewan Blood and Marrow Transplant Program, and most recently Medical Director of Oncology at the Saskatoon Cancer Clinic.

Dr. Stakiw’s clinical and research focus is on lymphoid malignancies, primarily multiple myeloma. She has been the primary investigator on numerous clinical trials and most recently was the national primary investigator for the Canadian Myeloma Research Group.